Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Change in Receivables came in at $53.0 million in Q2 2026, up 6.0% on a YoY basis from $50.0 million in Q2 2025, and up 149.07% quarter-over-quarter from -$108.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Change in Receivables (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Change in Receivables for 6 consecutive years, with $53.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 6.0% year-over-year to $53.0 million; the trailing twelve-month figure through Jun 2026 stood at $89.0 million (up 36.92% YoY), and the FY2025 full-year result was $148.0 million, down 34.8% from the prior year.
- Change in Receivables improved to $53.0 million in Q2 2026 per BLCO's latest filing, from -$108.0 million in the prior quarter.
- Across five years, Change in Receivables topped out at $130.0 million in Q4 2025 and bottomed at -$108.0 million in Q1 2026.
- Historically, Change in Receivables has averaged $29.8 million across 5 years, with a median of $33.0 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables jumped 2700.0% in 2023, then tumbled 825.0% in 2024.
- Over 5 years, Change in Receivables stood at $27.0 million in 2022, then jumped by 44.44% to $39.0 million in 2023, then surged by 205.13% to $119.0 million in 2024, then gained by 9.24% to $130.0 million in 2025, then sank by 59.23% to $53.0 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $53.0 million, -$108.0 million, and $130.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 53.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.00 Mn |
| Mar 31, 2026 | -108.00 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Dec 31, 2024 | 119.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Mar 31, 2024 | 92.00 Mn |
| Dec 31, 2023 | 39.00 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | 84.00 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Dec 31, 2022 | 27.00 Mn |
| Sep 30, 2022 | 44.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 21.00 Mn |
| Dec 31, 2021 | 76.00 Mn |
| Sep 30, 2021 | 6.00 Mn |